An estimated 7 million Omnipod insulin pods could have manufacturing errors leading to under-delivery of the medicine, the manufacturer said in an alert.
WASHINGTON — An estimated 7 million Omnipod insulin pods are under a voluntary Medical Device Correction due to a manufacturing error that can make the pods under-deliver insulin.
The alert, issued by Insulet Corporation, Inc. and the FDA on May 26, comes after 24 reports of “serious adverse events” including hospitalization caused by high blood glucose levels due to the under-delivery. No deaths have been reported.
The correction said a manufacturing error caused
Our editorial team includes several staff writers, each contributing their specialized knowledge to enhance the depth and breadth of our event and story coverage.